Latest filing published 24 Feb 2026 for Lucid Diagnostics Inc.. Read the official filing
No signal scores available.
James L. Cox is a declared insider at 3 companies; the most frequent names are Lucid Diagnostics Inc., Adagio Medical Holdings, Inc. and PAVmed Inc. In total, 4 filings cover trades dated from 22 February 2024 to 20 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 24 February 2026, reports a share grant in Lucid Diagnostics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations